http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02076399-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d054b5702fed9bd0aa96412f4649512
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91362464bee552b454b17b39ecc59665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14778be6e3a0b52c1959c8f79a159257
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee535c4180dfd1ed8d15212632306d99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2869c497a26eafd6aae2405fe128ed8d
publicationDate 2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02076399-A3
titleOfInvention YOHIMBINE DIMERS EXHIBITING BINDING SELECTIVITES FOR α2 ADRENERGIC RECEPTORS
abstract The present invention relates to yohimbine dimer compounds, pharmaceutical compositions containing such dimer compounds, methods of making such dimer compounds, and uses thereof. The yohimbine dimer compounds include compounds of formula (I), where R is any linker molecule which affords a yohimbine dimer that has a activity as an α2-AR antagonist and has selectivity fo an α2 -AR subtype over another α2-AR subtype.
priorityDate 2001-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3940387-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8969

Total number of triples: 18.